Therapeutic Targeting of the TGF-beta Signaling Axis to Modulate the Tumor Immune Microenvironment and Enhance Melanoma Immunotherapy

Administered By

Awarded By

Contributors

Start/End

  • November 1, 2013 - January 31, 2017